1.
Wijdan Abdullameer Kamel. Biochemical and Clinical Evaluation of Novel Tyrosine Kinase Inhibitors in Breast Cancer: Molecular Docking and Biomarker Correlation Study. IJSRIS [Internet]. 2026 Apr. 2 [cited 2026 May 15];5(2):252-65. Available from: https://www.ijsrisjournal.com/index.php/ojsfiles/article/view/653